| Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology RE Turnham, JD Scott Gene 577 (2), 101-108, 2016 | 226 | 2016 |
| Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma KM Riggle, KJ Riehle, HL Kenerson, R Turnham, MK Homma, M Kazami, ... Pediatric research 80 (1), 110-118, 2016 | 64 | 2016 |
| Fibrolamellar hepatocellular carcinoma: mechanistic distinction from adult hepatocellular carcinoma KM Riggle, R Turnham, JD Scott, RS Yeung, KJ Riehle Pediatric blood & cancer 63 (7), 1163-1167, 2016 | 52 | 2016 |
| An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma RE Turnham, FD Smith, HL Kenerson, MH Omar, M Golkowski, I Garcia, ... Elife 8, e44187, 2019 | 51 | 2019 |
| MicroRNA-375 suppresses the growth and invasion of fibrolamellar carcinoma TA Dinh, ML Jewell, M Kanke, A Francisco, R Sritharan, RE Turnham, ... Cellular and molecular gastroenterology and hepatology 7 (4), 803-817, 2019 | 34 | 2019 |
| Structural insight into the separate roles of inositol tetraphosphate and deacetylase‐activating domain in activation of histone deacetylase 3 M Arrar, R Turnham, L Pierce, CAF de Oliveira, JA McCammon Protein Science 22 (1), 83-92, 2013 | 31 | 2013 |
| Rapid deployment of SARS-CoV-2 testing: The CLIAHUB ED Crawford, I Acosta, V Ahyong, EC Anderson, S Arevalo, D Asarnow, ... PLoS pathogens 16 (10), e1008966, 2020 | 22 | 2020 |
| Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms GKL Chan, S Maisel, YC Hwang, BC Pascual, RRB Wolber, P Vu, ... Elife 12, e69521, 2023 | 13 | 2023 |
| Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma KJ Riehle, HL Kenerson, KM Riggle, R Turnham, K Sullivan, R Bauer, ... Oncotarget 10 (49), 5092, 2019 | 8 | 2019 |
| Development of a New Generation of Waste Form for Entrapment and Immobilization of Highly Volatile and Soluble Radionuclides Y Wang, H Gao, CJ Brinker, Y Xiong, K Holt, A Miller, P Pohl, N Ockwig, ... SANDIA Reports, Sandia National Laboratories, Albuquerque, 1-56, 2010 | 4 | 2010 |
| HBV rewires liver cancer signaling by altering PP2A complexes A Pitea, RE Turnham, M Eckhardt, GM Jang, Z Xu, HC Lim, A Choi, ... bioRxiv, 2023.03. 15.532845, 2023 | | 2023 |
| PMEPA1 has an oncogenic role in the context of TGF-beta signaling in hepatocellular carcinoma R Turnham, K Lo, Y Hwang, J Gordan CLINICAL CANCER RESEARCH 28 (17), 2022 | | 2022 |
| Abstract PR01: Computational identification of targetable dependencies in hepatocellular carcinoma (HCC) associated with hepatitis B virus (HBV) replication HC Lim, R Turnham, K Lo, Y Hwang, J Gordan Clinical Cancer Research 28 (17_Supplement), PR01-PR01, 2022 | | 2022 |
| Abstract PO017: HBV alters YAP regulation in liver cancer by remodeling PP2A complexes J Gordan, A Pitea, RE Turnham, M Eckhardt, GM Jang, H Lim, AL Choi, ... Clinical Cancer Research 28 (17_Supplement), PO017-PO017, 2022 | | 2022 |
| Abstract PO023: Uncovering hepatitis B virus-induced signaling changes in hepatocellular carcinoma RE Turnham, HC Lim, L Ferret, K Lo, LA Wang, A Choi, JD Gordan Clinical Cancer Research 28 (17_Supplement), PO023-PO023, 2022 | | 2022 |
| Uncovering pathogenesis of the DNAJ-PKAc fusion in fibrolamellar carcinoma RE Turnham | | 2018 |
